MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
3. Government_Funders & Regulators
*Government: International
Europe
*Europe: Regions
*Western Europe
Switzerland
*Industry: Switzerland
GenKyoTex
Parents
*Architects: Diabetes, Metabolic Disease, Dialysis, Renal & Kidney Companies (Pharmaceuticals, Biotechnology, Biosimilars)
*Industry: Switzerland
Venture Capital: Series C
Children
Clinical-stage pharmaceutical company focused on the treatment of complications of diabetes including diabetic nephropathy, GenKyoTex
Closed a $20.8M Series C financing (2011)
GenKyoTex S A Raises 26 Million for Phase II (2012)
Participants include Edmond de Rothschild Investment Partners, Vesalius Biocapital, MP Healthcare Venture Management and Specialized European Fund for Therapeutic Innovation.